CARUBBI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.040
EU - Europa 3.444
AS - Asia 1.225
SA - Sud America 20
AF - Africa 16
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.755
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.013
GB - Regno Unito 1.315
IT - Italia 748
SE - Svezia 376
SG - Singapore 376
CN - Cina 366
DE - Germania 359
HK - Hong Kong 205
TR - Turchia 181
UA - Ucraina 178
FI - Finlandia 125
FR - Francia 108
BG - Bulgaria 81
IN - India 28
CA - Canada 25
ID - Indonesia 21
NL - Olanda 21
RO - Romania 20
BE - Belgio 19
RU - Federazione Russa 16
IE - Irlanda 14
LT - Lituania 13
IR - Iran 12
EG - Egitto 11
CZ - Repubblica Ceca 10
ES - Italia 8
QA - Qatar 8
VN - Vietnam 8
BR - Brasile 7
MY - Malesia 7
AU - Australia 5
GR - Grecia 5
MK - Macedonia 5
PL - Polonia 5
CH - Svizzera 4
CO - Colombia 4
EU - Europa 4
PH - Filippine 4
SI - Slovenia 4
SA - Arabia Saudita 3
AT - Austria 2
BO - Bolivia 2
BZ - Belize 2
CL - Cile 2
EC - Ecuador 2
JP - Giappone 2
PE - Perù 2
RS - Serbia 2
AL - Albania 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BF - Burkina Faso 1
DK - Danimarca 1
ET - Etiopia 1
JO - Giordania 1
KR - Corea 1
LU - Lussemburgo 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 11.755
Salva come PNG Salva come JPEG
Città #
Southend 1.062
Fairfield 889
Chandler 659
Woodbridge 641
Ashburn 507
Santa Clara 479
Houston 434
Jacksonville 389
Seattle 340
Wilmington 326
Cambridge 320
Singapore 304
Dearborn 297
Ann Arbor 255
Nyköping 243
Hong Kong 198
Modena 126
Beijing 115
Izmir 110
San Diego 102
Princeton 92
Bremen 83
Sofia 81
Eugene 70
Grafing 61
Helsinki 60
New York 58
Des Moines 56
Falls Church 41
London 37
Milan 37
Reggio Emilia 27
Shanghai 25
Rome 24
Bologna 23
Parma 23
Jakarta 21
Brussels 19
Redwood City 19
Nanjing 18
Boardman 17
Timisoara 15
Norwalk 14
Fremont 13
Ottawa 13
Guangzhou 12
Munich 12
Verona 12
Dublin 11
Frankfurt am Main 11
Abbiategrasso 10
Hefei 10
Amsterdam 9
Kunming 9
Phoenix 9
Doha 8
Dong Ket 8
Florence 8
Los Angeles 8
Naples 8
Auburn Hills 7
Jinan 7
Mumbai 7
Padova 7
Brno 6
Dallas 6
Genova 6
Hounslow 6
Kilburn 6
Monza 6
San Mateo 6
Santeramo in Colle 6
Shenyang 6
Turin 6
Wuhan 6
Brescia 5
Formia 5
Leawood 5
Manchester 5
Palermo 5
Pisa 5
Toronto 5
Barcelona 4
Bari 4
Bobbio 4
Ferrara 4
Marcianise 4
Nanchang 4
Paris 4
Ravenna 4
Rho 4
Washington 4
Ankara 3
Arienzo 3
Avigliano 3
Busto Arsizio 3
Cagliari 3
Catania 3
Chiswick 3
Hebei 3
Totale 9.081
Salva come PNG Salva come JPEG
Nome #
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 390
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 270
A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease 262
The association of Mediterranean diet and exercise modifications with anthropometric parameters in a psychiatric community population: A pilot study 231
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 227
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 225
Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene 224
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 216
New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy 214
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 202
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 199
Growth of human herpesvirus 6 in HepG2 cells 196
Management of bone disease in Gaucher disease type 1: clinical practice 193
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 186
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 184
Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins 179
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 178
Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes 178
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 174
The time has come to look for metabolic dysfunction-associated fatty liver disease in adult patients with type 1 Gaucher disease 174
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease 172
Erratum to: Management of Bone Disease in Gaucher Disease Type 1: Clinical Practice 169
Cholesterol esterase activity of human intestinal mucosa 168
Fabry disease: raising awareness of the disease among physicians 168
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years 168
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 162
Review article: effect of bile salt pool composition on hepatic and biliary functions 162
Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease 158
Minimal disease activity in Gaucher disease: criteria for definition 154
"Assay of HMG-CoA reductase activity in the evaluation of cholesterol synthesis in man". 153
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 152
Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study 148
Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis 146
Effectiveness of dietetic counselling in lowering plasma cholesterol of children affected by hypercholesterolemia 143
Anatomia e fisiologia delle vie biliari 143
Nonalcoholic fatty liver disease induced by leuprorelin acetate 143
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 142
Atrial Dysfunction Assessed by Cardiac Magnetic Resonance as an Early Marker of Fabry Cardiomyopathy 142
Bile acid structure and regulation of biliary protein secretion and composition in man 137
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 136
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 136
Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease 135
Cholesterol Esterase Activity of human intestinal mucosa 134
Cholesterol esterase activity of human intestinal mucosa 132
MECCANISMI DI CITOTOSSICITÀ DEGLI ACIDI BILIARI. 130
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 125
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 124
Regulation of cholesterol absorption in humans 124
"Bile acid synthesis: metabolism of 3B-OH-5-cholenoic acid to chenodeoxycholic acid" 123
Hyperferritinemia and diagnosis of type 1 Gaucher disease 119
Effect of aging on cholesterol 7 alpha-hydroxylation in humans 116
Patogenesi della colelitiasi 113
Association of nonalcoholic fatty liver disease (Nafld) with peripheral diabetic polyneuropathy: A systematic review and meta-analysis 113
Rupture d'un anevrysme de l'aorte infecté par salmonelle. 110
Prevalence rates of gallstone disease in Italy: the Chianciano population study 107
Parkinson's disease in Gaucher disease patients: What's changing in the counseling and management of patients and their relatives? 106
Regulation of bile acid synthesis in humans: studies on cholesterol 7alpha-hydroxylation 'in vivo' 101
Dislipidemie.In Teodori 2004. Trattato italiano di medicina interna 99
Gaucher Disease in Bone: From Pathophysiology to Practice 99
Bile acid and hepatocyte death 97
Nuove prospettive terapeutiche con acidi biliari. 96
Effects of bile acid pool composition on hepatic metabolism of cholesterol in man 95
Deoxycholic acid (DCA) feeding induces significant changes of biliary lipid composition in cirrhotic patients 94
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report. 93
EFFECT OF CHENODEOXYCHOLIC ACID AND URSODEOXYCHOLIC ACID ADMINISTRATION ON ACYL-COA - CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN HUMAN LIVER 93
Inquadramento delle sindromi colestatiche. 92
Incidence of colorectal cancer and polyps in a health care district: experience at 1 year of registration 92
Regulation of bile acid synthesis in humans 90
Malattie delle vie biliari 89
Cholesterol esterase activity in the small bowel of humans 89
Quality of life in adult patients with glycogen storage disease type i: Results of a multicenter Italian study 89
Pancreatic cholesterol esterase of intestinal mucosa: characterization of enzymatic activity in humans 88
Effect of Chenodeoxycholic acid and Ursodeoxycholic acid administration on acyl-CoA: cholesterol acyl tranferase activity in human liver. 87
Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist 86
Nutrition in adult patients with selected lysosomal storage diseases 81
LA SECREZIONE LIPIDICA BILIARE 80
Effect of feeding small doses of deoxycholic acid on bile lipid composition in patients with liver cirrhosis 80
Effects of bariatric and metabolic surgical procedures on dyslipidemia: a retrospective, observational analysis. 79
A case of statin-induced liver injury with positive rechallenge with a second statin. Is there a class effect? 79
Fattori di rischio della litiasi biliare: importanza dell'alimentazione 70
Global multi-stakeholder endorsement of the MAFLD definition 69
Liver metastases from carcinoid tumor: Imaging patterns 62
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 59
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 43
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 29
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 28
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study 24
Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy-a Delphi consensus 23
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 20
Long-term bone outcomes in Italian patients with Gaucher disease type 1 or type 3 treated with imiglucerase: A sub-study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry 19
Long-term outcome of a cohort of Italian patients affected with alpha-Mannosidosis 17
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 13
Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis 12
How to overcome barriers to the implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy 9
Totale 11.880
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.129
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.568 0 0 0 0 189 330 387 199 177 85 115 86
2020/20211.886 139 56 117 168 147 84 352 317 93 206 106 101
2021/20221.764 89 202 125 121 94 148 71 64 196 126 370 158
2022/20231.755 164 165 126 188 244 293 34 168 190 29 85 69
2023/20241.042 37 62 59 86 232 93 101 137 22 56 51 106
2024/20251.045 134 54 61 279 517 0 0 0 0 0 0 0
Totale 11.880